5 Analysts Have This to Say About Compugen
Portfolio Pulse from Benzinga Insights
In the last quarter, Compugen (NASDAQ:CGEN) received 4 bullish and 1 somewhat bullish ratings from analysts. The average 12-month price target for the company has increased by 47.5% from $8.00 to $11.8.
August 07, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Compugen has received positive analyst ratings and an increased price target, indicating a positive outlook for the company.
The positive analyst ratings and increased price target suggest that analysts have a positive outlook for Compugen. This could lead to increased investor confidence and potentially a rise in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100